Dr. Jitendra Jagtap, consultant urologist and transplant surgeon, took center stage at the 2023 ASCO Direct Genitourinary Cancer Symposium in Chennai. While he presented abstracts, the symposium was a treasure trove of insights into upcoming therapies for urological cancers.

Dr. Jagtap presented real-world combination therapy patterns, with a focus on patients who had undergone either leuprolide or relugolix treatments for Androgen Deprivation Therapy (ADT). His analysis, drawing from a comprehensive US electronic medical records (EMR) database, unearthed critical strategies for optimizing ADT regimens.

This research milestone holds immense promise for the field of urology and offers potential avenues for more efficacious patient care.